• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Crystal structure of a covalent intermediate in DNA cleavage and rejoining by Escherichia coli DNA topoisomerase I.大肠杆菌 DNA 拓扑异构酶 I 介导的 DNA 断裂和连接的共价中间体的晶体结构。
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6939-44. doi: 10.1073/pnas.1100300108. Epub 2011 Apr 11.
2
The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining.严格保守的大肠埃希氏菌拓扑异构酶 I 活性部位的 Arg-321 残基在 DNA 重连中起着关键作用。
J Biol Chem. 2011 May 27;286(21):18673-80. doi: 10.1074/jbc.M111.229450. Epub 2011 Apr 7.
3
Analysis of RuvABC and RecG involvement in the escherichia coli response to the covalent topoisomerase-DNA complex.分析 RuvABC 和 RecG 在大肠杆菌应对共价拓扑异构酶-DNA 复合物中的作用。
J Bacteriol. 2010 Sep;192(17):4445-51. doi: 10.1128/JB.00350-10. Epub 2010 Jul 2.
4
Residues of E. coli topoisomerase I conserved for interaction with a specific cytosine base to facilitate DNA cleavage.大肠杆菌拓扑异构酶 I 的残基被保守用于与特定的胞嘧啶碱基相互作用,以促进 DNA 断裂。
Nucleic Acids Res. 2012 Oct;40(18):9233-43. doi: 10.1093/nar/gks688. Epub 2012 Jul 24.
5
Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule.IA型DNA拓扑异构酶与单链DNA分子复合物的晶体结构。
Nature. 2001 Jun 28;411(6841):1077-81. doi: 10.1038/35082615.
6
Experimental and computational investigations of Ser10 and Lys13 in the binding and cleavage of DNA substrates by Escherichia coli DNA topoisomerase I.大肠杆菌DNA拓扑异构酶I对DNA底物的结合与切割中Ser10和Lys13的实验与计算研究
Nucleic Acids Res. 2006 Mar 31;34(6):1785-97. doi: 10.1093/nar/gkl109. Print 2006.
7
The type IA topoisomerase catalytic cycle: A normal mode analysis and molecular dynamics simulation.IA型拓扑异构酶催化循环:正常模式分析与分子动力学模拟
Proteins. 2008 Jun;71(4):1984-94. doi: 10.1002/prot.21876.
8
Site-directed mutagenesis of residues involved in G Strand DNA binding by Escherichia coli DNA topoisomerase I.大肠杆菌DNA拓扑异构酶I中参与G链DNA结合的残基的定点诱变。
J Biol Chem. 2004 Sep 17;279(38):39207-13. doi: 10.1074/jbc.M405891200. Epub 2004 Jun 23.
9
Structural studies of E. coli topoisomerase III-DNA complexes reveal a novel type IA topoisomerase-DNA conformational intermediate.大肠杆菌拓扑异构酶III-DNA复合物的结构研究揭示了一种新型IA型拓扑异构酶-DNA构象中间体。
J Mol Biol. 2007 Apr 20;368(1):105-18. doi: 10.1016/j.jmb.2007.01.065. Epub 2007 Feb 3.
10
Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I.痘苗病毒DNA拓扑异构酶I突变体与DNA的共价和非共价结合
J Biol Chem. 1992 Aug 5;267(22):15984-92.

引用本文的文献

1
Unraveling the Role of Topoisomerase 3β (TOP3B) in mRNA Translation and Human Disease.解析拓扑异构酶3β(TOP3B)在mRNA翻译及人类疾病中的作用
Wiley Interdiscip Rev RNA. 2025 Jul-Aug;16(4):e70020. doi: 10.1002/wrna.70020.
2
Networked Salt-Bridges Mediate Magnesium-Dependent Conformational Dynamics and Functional Regulation in Type IA Topoisomerases.网络化盐桥介导IA型拓扑异构酶中依赖镁离子的构象动力学和功能调控。
Res Sq. 2025 Jul 14:rs.3.rs-7087376. doi: 10.21203/rs.3.rs-7087376/v1.
3
Substrate binding of human and bacterial type IA topoisomerase: An experimentation with AlphaFold 3.0.人类和细菌IA型拓扑异构酶的底物结合:使用AlphaFold 3.0进行的实验
Comput Struct Biotechnol J. 2025 Mar 27;27:1342-1349. doi: 10.1016/j.csbj.2025.03.041. eCollection 2025.
4
Structural insights into human topoisomerase 3β DNA and RNA catalysis and nucleic acid gate dynamics.对人类拓扑异构酶3β的DNA和RNA催化以及核酸门控动力学的结构见解。
Nat Commun. 2025 Jan 19;16(1):834. doi: 10.1038/s41467-025-55959-y.
5
Insights into the DNA and RNA Interactions of Human Topoisomerase III Beta Using Molecular Dynamics Simulations.运用分子动力学模拟深入探究人源拓扑异构酶 IIIβ 的 DNA 和 RNA 相互作用。
J Chem Inf Model. 2024 Aug 12;64(15):6062-6071. doi: 10.1021/acs.jcim.4c00472. Epub 2024 Jul 18.
6
Variation of Structure and Cellular Functions of Type IA Topoisomerases across the Tree of Life.结构和细胞功能的变化 I 型拓扑异构酶在生命之树。
Cells. 2024 Mar 21;13(6):553. doi: 10.3390/cells13060553.
7
What's on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases.门的另一侧是什么:I 型和 IIA 型 DNA 拓扑异构酶 DNA 门控开启的结构视角。
Int J Mol Sci. 2023 Feb 16;24(4):3986. doi: 10.3390/ijms24043986.
8
The interaction between transport-segment DNA and topoisomerase IA-crystal structure of MtbTOP1 in complex with both G- and T-segments.结核分枝杆菌拓扑异构酶 IA 与 G-和 T-片段复合物的晶体结构中,转运片段 DNA 与拓扑异构酶 IA 的相互作用。
Nucleic Acids Res. 2023 Jan 11;51(1):349-364. doi: 10.1093/nar/gkac1205.
9
Microbial Type IA Topoisomerase C-Terminal Domain Sequence Motifs, Distribution and Combination.微生物 I 型拓扑异构酶 C 末端结构域序列基序、分布和组合。
Int J Mol Sci. 2022 Aug 5;23(15):8709. doi: 10.3390/ijms23158709.
10
Structural and biochemical basis for DNA and RNA catalysis by human Topoisomerase 3β.人类拓扑异构酶 3β的 DNA 和 RNA 催化的结构和生化基础。
Nat Commun. 2022 Aug 9;13(1):4656. doi: 10.1038/s41467-022-32221-3.

本文引用的文献

1
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae.耐多药肠杆菌科中令人震惊的β-内酰胺酶介导的耐药性。
Curr Opin Microbiol. 2010 Oct;13(5):558-64. doi: 10.1016/j.mib.2010.09.006. Epub 2010 Oct 1.
2
New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?新德里金属β-内酰胺酶(NDM-1):会引发一场新的大流行吗?
Clin Microbiol Infect. 2010 Dec;16(12):1699-701. doi: 10.1111/j.1469-0691.2010.03385.x.
3
The dilemma of multidrug-resistant gram-negative bacteria.多重耐药革兰氏阴性菌的困境。
Am J Med Sci. 2010 Sep;340(3):232-7. doi: 10.1097/MAJ.0b013e3181e939c3.
4
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.DNA拓扑异构酶及其被抗癌和抗菌药物抑制的情况。
Chem Biol. 2010 May 28;17(5):421-33. doi: 10.1016/j.chembiol.2010.04.012.
5
Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.对鲍曼不动杆菌密切相关分离株中抗生素耐药决定因素的基因组分析。
Antimicrob Agents Chemother. 2010 Sep;54(9):3569-77. doi: 10.1128/AAC.00057-10. Epub 2010 Jun 7.
6
Up against the wall.靠墙站好。
Nat Med. 2010 Jun;16(6):628-31. doi: 10.1038/nm0610-628.
7
A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.一种新型统一的 II 型和 IA 拓扑异构酶切割 DNA 的双金属机制。
Nature. 2010 Jun 3;465(7298):641-4. doi: 10.1038/nature08974.
8
Hospital-acquired infections due to gram-negative bacteria.革兰氏阴性菌引起的医院获得性感染。
N Engl J Med. 2010 May 13;362(19):1804-13. doi: 10.1056/NEJMra0904124.
9
Hydroxyl radicals are involved in cell killing by the bacterial topoisomerase I cleavage complex.羟基自由基参与细菌拓扑异构酶I切割复合物的细胞杀伤作用。
J Bacteriol. 2009 Aug;191(16):5315-9. doi: 10.1128/JB.00559-09. Epub 2009 Jun 12.
10
DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.DNA拓扑异构酶I抑制剂:化学、生物学及界面抑制
Chem Rev. 2009 Jul;109(7):2894-902. doi: 10.1021/cr900097c.

大肠杆菌 DNA 拓扑异构酶 I 介导的 DNA 断裂和连接的共价中间体的晶体结构。

Crystal structure of a covalent intermediate in DNA cleavage and rejoining by Escherichia coli DNA topoisomerase I.

机构信息

Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York, NY 10595, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6939-44. doi: 10.1073/pnas.1100300108. Epub 2011 Apr 11.

DOI:10.1073/pnas.1100300108
PMID:21482796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3084087/
Abstract

DNA topoisomerases control DNA topology by breaking and rejoining DNA strands via covalent complexes with cleaved DNA substrate as catalytic intermediates. Here we report the structure of Escherichia coli topoisomerase I catalytic domain (residues 2-695) in covalent complex with a cleaved single-stranded oligonucleotide substrate, refined to 2.3-Å resolution. The enzyme-substrate intermediate formed after strand cleavage was captured due to the presence of the D111N mutation. This structure of the covalent topoisomerase-DNA intermediate, previously elusive for type IA topoisomerases, shows distinct conformational changes from the structure of the enzyme without bound DNA and provides detailed understanding of the covalent catalysis required for strand cleavage to take place. The portion of cleaved DNA 5' to the site of cleavage is anchored tightly with extensive noncovalent protein-DNA interactions as predicted by the "enzyme-bridged" model. Distortion of the scissile strand at the -4 position 5' to the cleavage site allows specific selectivity of a cytosine base in the binding pocket. Many antibacterial and anticancer drugs initiate cell killing by trapping the covalent complexes formed by topoisomerases. We have demonstrated in previous mutagenesis studies that accumulation of the covalent complex of bacterial topoisomerase I is bactericidal. This structure of the covalent intermediate provides the basis for the design of novel antibiotics that can trap the enzyme after formation of the covalent complex.

摘要

DNA 拓扑异构酶通过形成与断裂 DNA 底物共价结合的催化中间体来控制 DNA 的拓扑结构。在此,我们报道了与断裂的单链寡核苷酸底物共价结合的大肠杆菌拓扑异构酶 I 催化结构域(残基 2-695)的结构,分辨率为 2.3Å。由于存在 D111N 突变,在链断裂后形成的酶-底物中间产物被捕获。这种以前难以捉摸的 I 型拓扑异构酶的共价拓扑异构酶-DNA 中间产物结构,与没有结合 DNA 的酶的结构表现出明显的构象变化,并提供了对发生链断裂所需的共价催化的详细理解。与“酶桥接”模型预测的一致,断裂 DNA 5' 端的部分与广泛的非共价蛋白质-DNA 相互作用紧密结合。在切割位点 5' 处的断裂链的扭曲允许在结合口袋中对胞嘧啶碱基进行特异性选择。许多抗菌和抗癌药物通过捕获拓扑异构酶形成的共价复合物来启动细胞杀伤。我们在以前的突变研究中证明,细菌拓扑异构酶 I 的共价复合物的积累具有杀菌作用。这种共价中间产物的结构为设计新型抗生素提供了基础,这些抗生素可以在形成共价复合物后捕获酶。